Prostate cancer (PCa) affects millions of men globally. Due to advances in understanding
genomic landscapes and biological functions, the treatment of PCa continues to improve …

Due to the constantly increasing number of cases, prostate cancer has become one of the
most important health problems of modern societies. This review presents the current …

Background A remarkable therapeutic efficacy has been demonstrated with 225 Ac-prostate-
specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant …

Therapeutic failure in prostate cancer (PC) is believed to result from its unusually invasive
and metastatic nature. Cancer-associated fibroblasts (CAFs) are essential in the tumor …

Prostate cancer is a major cause of cancer‐related deaths among men worldwide. In
addition to genomic alterations, epigenetic alterations accumulated in prostate cancer have …

The histone lysine methyltransferase DOT1L (DOT1-like histone lysine methyltransferase) is
responsible for the epigenetic regulation of gene expression through specific methylation of …

Widespread genome hypo-methylation and promoter hyper-methylation of epithelium-
specific genes are hallmarks of stable epithelial-to-mesenchymal transition (EMT), which in …

Simple Summary The lack of highly specific and sensitive biomarkers for the early detection
of prostate cancer (PCa) is a major barrier to its management. Volatilomics emerged as a …

Cancer has become a serious problem worldwide, as it represents the main cause of death,
and its incidence has increased over the years. A potential strategy to counter the growing …

Prostate cancer (PCa) is the most common non-skin cancer and the second leading cause
of cancer-related deaths in American men. Due to its long latency period, PCa is considered …